Navigation Links
Nektar Consolidates Research at Its State-of-the-Art R&D Center Located in San Francisco at Mission Bay
Date:3/20/2012

States Food and Drug Administration in May 2011, and Baxter's BAX 855, a long-acting PEGylated rFVIII program which is in Phase 1 clinical development.

Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.  Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "expect," "believe," "should," "may," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the value and potential of Nektar's R&D pipeline; the future identification and advancement of new drug candidates by Nektar's R&D organization; and our plans to initiate a Phase 2 clinical study for NKTR-181. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include, among othe
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a ... its President and Chief Executive Officer, David Hansen ... Investor Conference being held at the Luxe Sunset ... on June 1-3, 2015. Mr. Hansen will ... progress made in the last year and plans for ...
(Date:5/28/2015)... 28, 2015  IGI Laboratories, Inc. (NYSE MKT: IG), ... generic pharmaceutical company, today announced it has submitted its ... Food and Drug Administration (FDA) of 2015, which brings ... at the FDA to twenty-five. Jason ... "Our team continues to execute on the targets we ...
(Date:5/27/2015)... May 27, 2015 ... the addition of the  "2015 Strategies in ...  report to their offering.      ... to the UK NAT laboratory practice, as ... and technological trends with significant market impact ...
Breaking Medicine Technology:MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 2MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 3MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 4IGI Laboratories, Inc. Announces Third ANDA Submission Of 2015 2
... Reportlinker.com announces that a new market research report ... Drug Delivery in Central Nervous System Diseases - ... The delivery of drugs ... in the treatment of neurological disorders. Drugs may ...
... Robbins & Myers, Inc. (NYSE: ... its Romaco businesses to a group of funds led ... investment firm.  Total consideration was approximately euro 65 million ... and euro 4 million of assumed liabilities and is ...
Cached Medicine Technology:Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 2Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 3Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 4
(Date:5/28/2015)... 2015 Career Step, an online provider ... announce that Career Step Executive Vice President Mike Hodgson ... webinar presented by ICD10monitor in conjunction with Kimberly J. ... Hodgson and Ms. Carr will be discussing the importance ... transition. , “We have worked closely with HRS on ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Sunshine ... Treatment and Drug Rehabilitation programs at http://www.sunshinecoasthealthcentre.ca ... in its information outreach to the Toronto, Ontario, ... in Toronto, and has enhanced its online location ... is our primary treatment center, we realize that ...
(Date:5/28/2015)... May 28, 2015 Peggy J. Lynam, PT, ... to the American Physical Therapy Association House of Delegates for ... at their Delegate Assembly. This will be her second ... serves as coordinator and principle spokesperson for the Chapter delegation ... of Directors or Delegate Assembly may direct the Chief Delegate ...
(Date:5/28/2015)... 28, 2015 The 110-mile April 24-26 ... ride from national non-profit World T.E.A.M. Sports is featured ... Talking With Heroes . , Host Bob Calvert and ... veteran and civilian riders, sponsors and staff members. The ... includes a musical performance by The American Bombshells and ...
(Date:5/27/2015)... (PRWEB) May 28, 2015 Cincinnati Veterans ... informational Open House May 30 from noon-2p.m. in the ... about how caregivers can offer full-time assistance to Veterans ... through a comprehensive survey process conducted by the medical ... residence as a medical foster home, the caregiver must ...
Breaking Medicine News(10 mins):Health News:Career Step and HRS Hosting June 4 ICD10monitor Webinar on the Importance of Auditing and Physician Training for ICD-10 Success 2Health News:Career Step and HRS Hosting June 4 ICD10monitor Webinar on the Importance of Auditing and Physician Training for ICD-10 Success 3Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 2Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 3Health News:Videos Document World T.E.A.M. Sports' April 24-26 Face of America Bicycling Ride to Gettysburg 2Health News:Videos Document World T.E.A.M. Sports' April 24-26 Face of America Bicycling Ride to Gettysburg 3
... is available in German . Lung tumors ... one cancer in three is lung cancer. Each year, there are ... a tumor can be detected, the greater the chance of healing ... the tumor-related complaints resemble chronic inflammatory reactions. To get a more ...
... be active in killing cells also promotes cellular survival through ... is actually necessary for survival of septic injury, Future research ... developing new treatments for sepsis PROVIDENCE, R.I. ... plays a dual role in the liver during sepsis. The ...
... poverty have health problems as adults. But a new study ... social cohesiveness and control get some measure of protection; they,re ... The new study, published in Psychological Science , a ... a long-term examination of children growing up poor in rural ...
... these late effects of treatment, the health care services can, ... the treatment, and, on the other hand, find appropriate ways ... in adolescence and adulthood. The cancer care services in ... affected by cancer as early as 1987. Twenty years later, ...
... Amanda Gardner HealthDay Reporter , TUESDAY, Feb. ... many Americans have out-of-control blood pressure and cholesterol levels ... health officials warn. According to the latest report ... one-third of U.S. adults have hypertension (high blood pressure), ...
... gifts to medical science is stirring excitement with the ... inhabiting cyanobacterium appears to be an ideal blueprint ... other bone diseases. That,s the conclusion of a study ... Medicinal Chemistry Letters . By some estimates, more ...
Cached Medicine News:Health News:Early detection of lung cancer 2Health News:The 'death switch' in sepsis also promotes survival 2Health News:Having a strong community protects adolescents from risky health behaviors 2Health News:PanCareSurFup: Major EU project to tackle complications of childhood cancer treatment 2Health News:Half of Adults Have Hypertension or High Cholesterol: CDC 2Health News:Half of Adults Have Hypertension or High Cholesterol: CDC 3
... all-new Canon CF-60DSi is an all-digital Fundus camera ... and an efficient workflow. The ... The Canon EOS-1Ds series SLR digital camera features ... mega pixel resolution and the new ICG unit, ...
... quantum leap forward in the evolution of lens ... K lens has become the world's most frequently ... traditional contact lenses, the complex geometry built into ... cone like shape of the cornea, for every ...
... (MPM) devices allow physicians to successfully manage ... Aerotels MPM equipment, patients can sit in ... physicians conduct routine and comprehensive medical monitoring ... system, data is automatically recorded and transferred ...
... The Ellex Solitaire represents the latest ... ideal photocoagulator system for use in both ... concert with surgeon preference testing and the ... the world, Solitaire is the premium 532nm ...
Medicine Products: